Reviewing The Case For Bristol-Myers Squibb Co (BMY) Going Higher
Currently, there are 2.03B common shares owned by the public and among those 2.03B shares have been available to trade. The company’s stock has a 5-day price change of 3.03% and 7.26% over the past three months. BMY shares are trading 0.85% year to date (YTD), with the 12-month market performance up to 13.88% higher. […]
Now Is A Suitable Moment For A Long-Term Purchase Of Bristol-Myers Squibb Co (NYSE: BMY)
Currently, there are 2.03B common shares owned by the public and among those 2.03B shares have been available to trade. The company’s stock has a 5-day price change of -1.66% and 6.78% over the past three months. BMY shares are trading -1.45% year to date (YTD), with the 12-month market performance up to 10.99% higher. […]
These Numbers Could Change Investor Views For Bristol-Myers Squibb Co (NYSE: BMY)
Currently, there are 2.03B common shares owned by the public and among those 2.03B shares have been available to trade. The company’s stock has a 5-day price change of -1.73% and 5.04% over the past three months. BMY shares are trading 0.21% year to date (YTD), with the 12-month market performance up to 8.92% higher. […]
Uncovering Institutional Buying In Bristol-Myers Squibb Co (NYSE: BMY)
Currently, there are 2.03B common shares owned by the public and among those 2.03B shares have been available to trade. The company’s stock has a 5-day price change of -2.22% and 8.35% over the past three months. BMY shares are trading 9.26% year to date (YTD), with the 12-month market performance up to 9.45% higher. […]
Bristol-Myers Squibb Co (NYSE: BMY) Has Another Chance To Impress You
Currently, there are 2.03B common shares owned by the public and among those 2.03B shares have been available to trade. The company’s stock has a 5-day price change of 2.78% and 14.64% over the past three months. BMY shares are trading 11.73% year to date (YTD), with the 12-month market performance up to 12.50% higher. […]
Look At Analyst Expectations For A Better Read On Bristol-Myers Squibb Co (NYSE: BMY)
Currently, there are 2.03B common shares owned by the public and among those 2.03B shares have been available to trade. The company’s stock has a 5-day price change of -4.84% and 12.89% over the past three months. BMY shares are trading 8.89% year to date (YTD), with the 12-month market performance up to 8.55% higher. […]
Bristol-Myers Squibb Co. (BMY): Street Finally Waking Up
Currently, there are 2.02B common shares owned by the public and among those 2.02B shares have been available to trade. Insiders at the company have transacted a total of 136 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 85 of these insider trades were purchases, […]
Why Should You Put Bristol-Myers Squibb Co. (NYSE: BMY) On Your Portfolio?
Currently, there are 2.02B common shares owned by the public and among those 2.02B shares have been available to trade. Insiders at the company have transacted a total of 136 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 85 of these insider trades were purchases, […]
Now Is A Suitable Moment For A Long-Term Purchase Of Bristol-Myers Squibb Co. (NYSE: BMY)
Currently, there are 2.10B common shares owned by the public and among those 2.03B shares have been available to trade. Insiders at the company have transacted a total of 136 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 85 of these insider trades were purchases, […]
Bristol-Myers Squibb Co. (BMY) Volatility Spurs A Quest For Clarity
Currently, there are 2.10B common shares owned by the public and among those 2.03B shares have been available to trade. Insiders at the company have transacted a total of 138 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 85 of these insider trades were purchases, […]
